Early Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Early Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Early Evaluation Today - Breaking & Trending Today

Chipscreen NewWay: First Patient Dosed in Phase 1 Trial of the Bispecific Antibody NWY001, a Next-generation Tumor Immunotherapy in Patients with Advanced Solid Tumors

Published: January 16, 2024

/PRNewswire/ -- Chengdu Chipscreen NewWay Biosciences Co., Ltd. (NewWay) announced that on January 5, 2024, the dosing of the first patient for a phase I...

Source: prnewswire.com

Related Topics:

Hong KongUnited StatesSan FranciscoChipscreen Newway BiosciencesChipscreen NewwayHaimen JiangsuChipscreen BiosciencesChipscreen Biosciences United StatesShenzhen Chipscreen Pharmaceuticals Co LtdShanghai Business CenterBiocytogen Pharmaceuticals Beijing Co LtdPrnewswire Chengdu Chipscreen Newway Biosciences Co LtdShenzhen Chipscreen Biosciences Co LtdSun Yat Sen University Cancer CenterChengdu Chipscreen Pharmaceuticals Co LtdEucure Beijing Biopharma Co LtdChengdu Chipscreen Newway Biosciences Co LtdClinical Research CenterBin LiuScientific DirectorGreater ChinaMainland ChinaChengdu Hi Tech ZoneGenomics Based Integrated Drug DiscoveryEarly Evaluation